Use of patient-reported outcome measures for oncology drugs receiving accelerated approval
Crossref DOI link: https://doi.org/10.1007/s00520-023-08068-9
Published Online: 2023-09-29
Published Print: 2023-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moore, Donald C.
Elmes, Joseph B.
Strassels, Scott A.
Patel, Jai N.
Text and Data Mining valid from 2023-09-29
Version of Record valid from 2023-09-29
Article History
Received: 30 May 2023
Accepted: 22 September 2023
First Online: 29 September 2023
Declarations
:
: The authors declare no competing interests.